From selection to site activation
For this Phase 2b cardiovascular study, WCR reached site activation 28 calendar days after selection. That milestone opened the way for screening to begin.
Phase 2b · Cardiovascular
43 days to first screening. Five participants randomized.
WCR moved from site selection to first screening in 43 calendar days. All five participants in the initial screening group went on to randomization.
Explore the study storyStudy outcome
43calendar days from selection to first screening28days from selection to activation
15days from activation to first screening
5participants randomized
Inside the case
Screening began 15 days after activation
The first participant was screened 15 days after activation, or 43 days after site selection. By day 50, five participants had been screened.
Screening translated into enrollment
All five participants in that initial screening group were randomized. Early conversations about study expectations and continued participant contact supported strong compliance during participation. The result connects startup execution to an enrolled study population.
The challenge. Our response.
Carry startup momentum into participant readiness.
The operational challenge was to connect site readiness with a prepared initial screening group, then carry that group forward into enrollment.
From activation to the first screening
The challenge
Site activation had to translate into a practical first screening appointment and an informed participant.
How our team responds
We pair early screening preparation with clear conversations about the study commitment and participant availability. WCR reached first screening 15 days after activation, or 43 days after selection.
From an initial screening group to randomization
The challenge
The first five screenings needed continued participant engagement as candidates moved through the study process.
How our team responds
Our approach keeps communication open beyond the screening visit and prepares participants for the next steps. All five participants in the initial screened group went on to randomization.
Study outcome
43 days from selection to first screening. Five screened participants progressed to randomization.
The participant experience
Prepare for participation while preparing the site.
Moving quickly into screening also meant helping participants understand the commitment ahead. Our team set expectations early and maintained open communication as the initial screened group progressed to randomization, supporting strong compliance during participation.
Set expectations before screening
We discuss the study commitment early, including what participation will require and whether candidates feel ready to meet those expectations. Pre-screening helps establish a shared understanding before the first screening visit.
Build a working relationship
Participants need a team they can talk to. We build relationships throughout the study and keep communication open so questions and practical concerns can be raised with the site.
Keep the focus on follow-through
Our participant engagement approach continues beyond randomization. We stay connected throughout participation to support retention and compliance with study requirements.
Practical participant support
Help with the journey.
Support through the study.
We provide transportation support when needed to help participants attend study visits. We also discuss scheduling concerns early and maintain open communication throughout participation, helping address the practical barriers that can make follow-through difficult.
The result
43 days from selection to first screening. Five screened participants progressed to randomization.
Phase 2b · Cardiovascular · WCR case study
Your next study
Build your next study
on a stronger start.
Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.